Published in Am J Respir Crit Care Med on October 15, 2001
Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease. Thorax (2005) 2.69
The role of heme oxygenase-1 in pulmonary disease. Am J Respir Cell Mol Biol (2006) 1.59
Focus on antioxidant enzymes and antioxidant strategies in smoking related airway diseases. Thorax (2005) 1.35
Heme oxygenase-1 and carbon monoxide in pulmonary medicine. Respir Res (2003) 1.33
HNE increases HO-1 through activation of the ERK pathway in pulmonary epithelial cells. Free Radic Biol Med (2005) 1.10
Airway biomarkers of the oxidant burden in asthma and chronic obstructive pulmonary disease: current and future perspectives. Int J Chron Obstruct Pulmon Dis (2008) 1.00
Heme oxygenase-1: a novel therapeutic target for gastrointestinal diseases. J Clin Biochem Nutr (2011) 0.96
The genetics of chronic obstructive pulmonary disease. Respir Res (2006) 0.95
Identifying targets for COPD treatment through gene expression analyses. Int J Chron Obstruct Pulmon Dis (2008) 0.95
Heme oxygenase-1 prevents airway mucus hypersecretion induced by cigarette smoke in rodents and humans. Am J Pathol (2008) 0.89
Heme oxygenase-1 prevents smoke induced B-cell infiltrates: a role for regulatory T cells? Respir Res (2008) 0.89
Induction of heme oxygenase-1, biliverdin reductase and H-ferritin in lung macrophage in smokers with primary spontaneous pneumothorax: role of HIF-1alpha. PLoS One (2010) 0.89
Carbon monoxide in exhaled breath testing and therapeutics. J Breath Res (2013) 0.84
Oligosaccharides from agar inhibit murine intestinal inflammation through the induction of heme oxygenase-1 expression. J Gastroenterol (2012) 0.83
Strategies to decrease ongoing oxidant burden in chronic obstructive pulmonary disease. Expert Rev Clin Pharmacol (2012) 0.82
Gasotransmitters: novel regulators of epithelial na(+) transport? Front Physiol (2012) 0.81
Resolvin E1 maintains macrophage function under cigarette smoke-induced oxidative stress. FEBS Open Bio (2012) 0.77
A panoramic spectrum of complex interplay between the immune system and IL-32 during pathogenesis of various systemic infections and inflammation. Eur J Med Res (2015) 0.76
Important Role of the IL-32 Inflammatory Network in the Host Response against Viral Infection. Viruses (2015) 0.76
HO1 mRNA and Protein do not Change in Parallel in Bronchial Biopsies of Patients After Long Term Exposure to Sulfur Mustard. Gene Regul Syst Bio (2009) 0.75
Immunohistochemical expression of nuclear factor erythroid-2-related factor 2 and heme oxygenase 1 in normal bovine lung and bovine lung infected with Mannheimia haemolytica. Can J Vet Res (2015) 0.75
Airway responsiveness. Standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl (1993) 3.82
CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1998) 3.69
Airway eosinophilia in chronic bronchitis during exacerbations. Am J Respir Crit Care Med (1994) 3.06
Severity of airflow limitation is associated with severity of airway inflammation in smokers. Am J Respir Crit Care Med (1998) 2.62
Cellular and structural bases of chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2001) 2.58
Global Strategy for the Diagnosis, Management and Prevention of COPD: 2003 update. Eur Respir J (2003) 2.57
Airways obstruction, chronic expectoration, and rapid decline of FEV1 in smokers are associated with increased levels of sputum neutrophils. Thorax (1996) 2.52
CD8+ve cells in the lungs of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1999) 2.52
The C-C chemokine receptors CCR4 and CCR8 identify airway T cells of allergen-challenged atopic asthmatics. J Clin Invest (2001) 2.05
Fatal asthma attack during an inhalation challenge with ultrasonically nebulized distilled water. J Allergy Clin Immunol (1995) 2.04
Activated T-lymphocytes and macrophages in bronchial mucosa of subjects with chronic bronchitis. Am Rev Respir Dis (1993) 2.02
Roflumilast with long-acting β2-agonists for COPD: influence of exacerbation history. Eur Respir J (2011) 1.99
Neutrophilic infiltration within the airway smooth muscle in patients with COPD. Thorax (2004) 1.89
Exacerbations of Bronchitis: bronchial eosinophilia and gene expression for interleukin-4, interleukin-5, and eosinophil chemoattractants. Am J Respir Crit Care Med (2001) 1.88
Importance of airway inflammation for hyperresponsiveness induced by ozone. Am Rev Respir Dis (1983) 1.85
Decreased haem oxygenase-1 and increased inducible nitric oxide synthase in the lung of severe COPD patients. Eur Respir J (2003) 1.84
Inflammatory cells in the bronchial glands of smokers with chronic bronchitis. Am J Respir Crit Care Med (1997) 1.79
Macrophage expression of interleukin-10 is a prognostic factor in nonsmall cell lung cancer. Eur Respir J (2007) 1.73
Airway eosinophilia and expression of interleukin-5 protein in asthma and in exacerbations of chronic bronchitis. Clin Exp Allergy (1996) 1.72
Comparison of leukocyte counts in sputum, bronchial biopsies, and bronchoalveolar lavage. Am J Respir Crit Care Med (1995) 1.63
Association between markers of emphysema and more severe chronic obstructive pulmonary disease. Thorax (2006) 1.60
COPD increases the risk of squamous histological subtype in smokers who develop non-small cell lung carcinoma. Thorax (2004) 1.58
Effect of smoking cessation on airway inflammation in chronic bronchitis. Am J Respir Crit Care Med (1995) 1.55
Low domestic exposure to house dust mite allergens (Der p 1) is associated with a reduced non-specific bronchial hyper-responsiveness in mite-sensitized asthmatic subjects under optimal drug treatment. Clin Exp Allergy (2001) 1.52
Modification of the methacholine inhalation test and its epidemiologic use in polyurethane workers. Am Rev Respir Dis (1986) 1.49
Destructive index: a measurement of lung parenchymal destruction in smokers. Am Rev Respir Dis (1985) 1.45
Partial reversibility of airflow limitation and increased exhaled NO and sputum eosinophilia in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2000) 1.44
Use of a T-cell interferon-gamma release assay for the diagnosis of tuberculous pleurisy. Eur Respir J (2007) 1.44
Airflow limitation in chronic bronchitis is associated with T-lymphocyte and macrophage infiltration of the bronchial mucosa. Am J Respir Crit Care Med (1996) 1.44
Expiratory pattern of newborn mammals. J Appl Physiol (1985) (1985) 1.43
Prioritised research agenda for prevention and control of chronic respiratory diseases. Eur Respir J (2010) 1.41
Goblet cell hyperplasia and epithelial inflammation in peripheral airways of smokers with both symptoms of chronic bronchitis and chronic airflow limitation. Am J Respir Crit Care Med (2000) 1.40
Role of comorbidities in a cohort of patients with COPD undergoing pulmonary rehabilitation. Thorax (2008) 1.40
Venous blood platelets decrease during allergen-induced asthmatic reactions. Clin Exp Allergy (1990) 1.39
Beclomethasone/formoterol vs fluticasone/salmeterol inhaled combination in moderate to severe asthma. Allergy (2007) 1.36
Increased activation of p38 MAPK in COPD. Eur Respir J (2007) 1.33
Loss of alveolar attachments in smokers. A morphometric correlate of lung function impairment. Am Rev Respir Dis (1985) 1.30
Remodeling in response to infection and injury. Airway inflammation and hypersecretion of mucus in smoking subjects with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2001) 1.29
Control of neurotransmission by prostaglandins in canine trachealis smooth muscle. J Appl Physiol Respir Environ Exerc Physiol (1984) 1.27
Nuclear localisation of p65 in sputum macrophages but not in sputum neutrophils during COPD exacerbations. Thorax (2003) 1.26
Presence and bronchomotor activity of protease-activated receptor-2 in guinea pig airways. Am J Respir Crit Care Med (2000) 1.24
Neutrophil depletion inhibits airway hyperresponsiveness induced by ozone exposure. Am Rev Respir Dis (1984) 1.23
Upregulation of adhesion molecules in the bronchial mucosa of subjects with chronic obstructive bronchitis. Am J Respir Crit Care Med (1994) 1.20
Triggering receptor expressed on myeloid cells: role in the diagnosis of lung infections. Eur Respir J (2004) 1.20
Interleukin-13 and -4 expression in the central airways of smokers with chronic bronchitis. Eur Respir J (2003) 1.20
Airway hyperresponsiveness and changes in cell counts in bronchoalveolar lavage after ozone exposure in dogs. Am Rev Respir Dis (1984) 1.18
Bronchoalveolar neutrophilia during late asthmatic reactions induced by toluene diisocyanate. Am Rev Respir Dis (1987) 1.16
Antibodies to the IL-12 receptor beta 2 chain mark human Th1 but not Th2 cells in vitro and in vivo. J Immunol (1999) 1.15
The small airways and distal lung compartment in asthma and COPD: a time for reappraisal. Allergy (2009) 1.15
Vascular endothelial growth factor up-regulation and bronchial wall remodelling in asthma. Clin Exp Allergy (2005) 1.14
Occupational asthma due to isocyanates. Eur Respir J (1988) 1.13
Beclomethasone/formoterol versus budesonide/formoterol combination therapy in asthma. Eur Respir J (2006) 1.13
Repeated tuberculin testing does not induce false positive ELISPOT results. Thorax (2006) 1.13
Reference equations for the single-breath diffusing capacity. A cross-sectional analysis and effect of body size and age. Am Rev Respir Dis (1985) 1.12
Fatal asthma in a subject sensitized to toluene diisocyanate. Am Rev Respir Dis (1988) 1.12
Polymorphisms in IL13 pathway genes in asthma and chronic obstructive pulmonary disease. Allergy (2009) 1.09
Predominant emphysema phenotype in chronic obstructive pulmonary. Eur Respir J (2003) 1.09
Activated T-lymphocytes and eosinophils in the bronchial mucosa in isocyanate-induced asthma. J Allergy Clin Immunol (1992) 1.08
Standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults. Eur Respir J (1993) 1.06
Quantitative structural analysis of peripheral airways and arteries in sudden fatal asthma. Am Rev Respir Dis (1991) 1.06
Pathogenesis and pathology of COPD. Respiration (2001) 1.06
Occupational asthma and extrinsic alveolitis due to isocyanates: current status and perspectives. Br J Ind Med (1993) 1.03
Bronchial vascular remodelling in patients with COPD and its relationship with inhaled steroid treatment. Thorax (2009) 1.03
Reference values for vital capacity and flow-volume curves from a general population study. Bull Eur Physiopathol Respir (1987) 1.02
Association between HLA genes and susceptibility to toluene diisocyanate-induced asthma. Clin Exp Allergy (2000) 1.01
Indomethacin inhibits the airway hyperresponsiveness but not the neutrophil influx induced by ozone in dogs. Am Rev Respir Dis (1984) 1.00
Airway wall remodeling after cessation of exposure to isocyanates in sensitized asthmatic subjects. Am J Respir Crit Care Med (1995) 1.00
Effect of oxidant air pollutants on the respiratory system: insights from experimental animal research. Eur Respir J (1995) 1.00
Symbols, abbreviations and units. Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Eur Respir J Suppl (1993) 1.00
Sputum eosinophilia after asthmatic responses induced by isocyanates in sensitized subjects. Clin Exp Allergy (1994) 0.99
Prednisone inhibits late asthmatic reactions and airway inflammation induced by toluene diisocyanate in sensitized subjects. J Allergy Clin Immunol (1987) 0.99
HLA class II alleles in isocyanate-induced asthma. Am J Respir Crit Care Med (1994) 0.99
Efficacy of standard rehabilitation in COPD outpatients with comorbidities. Eur Respir J (2010) 0.98
Corticosteroid inhibition of airway microvascular leakage. Am Rev Respir Dis (1991) 0.98
Bronchoconstriction induced by citric acid inhalation in guinea pigs: role of tachykinins, bradykinin, and nitric oxide. Am J Respir Crit Care Med (1999) 0.96
Indacaterol provides sustained 24 h bronchodilation on once-daily dosing in asthma: a 7-day dose-ranging study. Allergy (2008) 0.95
Delivering effective asthma care--how do we implement asthma guidelines? Eur Respir J (2000) 0.95